Unplugged: Developing Standards for Wireless Automation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Unplugged: Developing Standards for Wireless Automation
ISA 100.11a and WirelessHART both seek to become the global standard for industrial wireless automation.


Pharmaceutical Technology


Profibus, Profibus International, Foundation Fieldbus, and HART have formed a working group to develop a specification that will give common interface using a wireless gateway. "We want to give users some assurance that whatever they chose [Foundation Fieldbus, Profibus, or Profinet], they are going to be able to use it going forward," says Carl Henning, deputy director at PTO, Profibus, and Profinet North America. According to Henning, the group will look at both WirelessHART and the ISA standard, although because WirelessHART is complete, Profibus has been working mainly with that standard. "I've been told that we will probably see the Profibus gateway by the end of the year. This should help users because it will result in a common interface so they won't be stuck deciding which wireless sensor network to choose."

Says Karschnia, "It seems it would be worthwhile for SP 100 to change its focus from the bit-and-byte communication sensors to bigger problem of gateways." (In a network, a sensor transmits data, the data hops through a time-synchronized mesh protocol network, and arrives at a gateway.) "ISA should focus on how does that gateway will interface to the rest of the process control systems that exists—to the DCS, to the historians, to the business systems, and to the diagnostics systems. Once someone defines that, then the industry will adopt wireless more readily. To date, Emerson has its solution, Honeywell have its solution, and everyone will have a different solution. That is where ISA can add value."

Henning offers this perspective: "The thing to remember is that it doesn't matter who puts out the standard, it's what the users adopt that is going to be important. From that standpoint, I like the idea of having competing standards. The users are winners by having competitions because the standards organizations are spurred on to do better by that competition. There is a limit, but I think with two or three competing technologies, it's a positive."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here